InspireMD, Inc. (NSPR): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$426.39M

Year ended 2025-12-31

+36.1%

3-year compound annual growth

2009-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	$426.39M	+73.0%	2026-03-18, From 2025-01-01
2024-12-31	$246.50M	+16.9%	2026-03-18, From 2024-01-01
2023-12-31	$210.86M	+24.6%	2025-03-12, From 2023-01-01
2022-12-31	$169.29M	n/m	2024-03-05, From 2022-01-01
2021-12-31	-$14.55M	n/m	2023-03-30, From 2021-01-01
2020-12-31	-$10.23M	n/m	2022-03-07, From 2020-01-01
2019-12-31	-$9.66M	n/m	2021-03-08, From 2019-01-01
2018-12-31	-$7.47M	n/m	2020-03-10, From 2018-01-01
2017-12-31	-$8.08M	n/m	2019-02-19, From 2017-01-01
2016-12-31	-$7.51M	n/m	2018-02-13, From 2016-01-01
2015-12-31	-$14.33M	n/a	2017-02-16, From 2015-01-01
No annual figure between 2010-12-31 and 2015-12-31.
2010-12-31	-$3.13M	n/m	2012-03-13, From 2010-01-01
2009-12-31	-$2.63M	n/a	2012-03-13, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
InspireMD, Inc. (NSPR)	2025-12-31	$426.39M	+73.0%
Neuroone Medical Technologies Corp (NMTC)	2025-09-30	-$3.96M	n/m
Medinotec Inc. (MDNC)	2026-02-28	$1.18M	-64.0%
Beyond Air, Inc. (XAIR)	2026-03-31	-$25.94M	n/m
Nexgel, Inc. (NXGL)	2025-12-31	-$2.90M	n/m
INVO Fertility, Inc. (IVF)	2025-12-31	-$6.56M	n/m
Allurion Technologies, Inc. (ALUR)	2025-12-31	-$29.17M	n/m
Cerenome, Inc. (CNSY)	2025-12-31	-$14.85M	n/m
Picard Medical, Inc. (PMI)	2025-12-31	-$13.09M	n/m

Compare NSPR, NMTC, MDNC, XAIR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗